A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression
Clinical trial NCT02422186 · COMPLETED
Trial details
- NCT number
- NCT02422186
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-20
- Primary completion
- 2017-08-10
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.